Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Is a new Alzheimer’s disease drug in the offing?

Posted on September 23rd, 2016 by in Pharma R&D

A high profile paper describing a prospective new therapy for Alzheimer’s disease (AD) was being shared around the internet recently. The paper, “The antibody aducanumab reduces Ab plaques in Alzheimer’s disease,” authored by Sevigny et al., was published on-line in Nature (Sevigny et al., 2016) and describes the preclinical and early clinical development of aducanumab, Continue reading “Is a new Alzheimer’s disease drug in the offing?” »

Impact of Precision Medicine and Genomics on Patient Treatment

Posted on August 26th, 2016 by in Chemistry

In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.

Continue reading “Impact of Precision Medicine and Genomics on Patient Treatment” »

A gathering of global perspectives ….. a look at DIA’s annual meeting: Post 1 of 2

Posted on July 11th, 2016 by in Pharma R&D

At the end of June, the Drug Information Association (DIA), held its annual conference with this year’s theme being “A Gathering of Global Perspectives.”  The meeting, held in Philadelphia, offered a wide variety of tracks from which you could “pick and mix” Continue reading “A gathering of global perspectives ….. a look at DIA’s annual meeting: Post 1 of 2” »

Building models for rare diseases

Posted on June 2nd, 2016 by in Pharma R&D

We continue the series of stories about the exciting collaboration between the UK charity Findacure and Elsevier. Findacure’s mission is to empower rare disease patient groups, facilitate treatment Continue reading “Building models for rare diseases” »